We empower biopharma and healthtech leaders to make faster, smarter decisions through primary intelligence, real-time conference coverage, and AI-powered strategic workshops.
We de-risk high-stakes decisions for biopharma and investors with evidence-led insight, tech-enabled analysis, and actionable recommendations.
Make better decisions, faster, across every therapy area
We deliver evidence-backed actionable insights and recommendations to help biopharma teams develop winning competitive strategies and accelerate differentiation.
How we deliver:
- Primary intelligence (KOL, industry and market stakeholder interviews)
- Conference coverage (all major conferences across therapy areas)
- AI-powered, human-in-the-loop wargames & workshops
- Secondary research and monitoring via proprietary tools
Navigate the intersection of healthcare and technology
We help biopharma and healthtech leaders capitalize on AI, digital health, and connected technologies. Our advisory services bridge the gap between clinical expertise and emerging tech, while our proprietary tools (LucidScope for AI answer intelligence, LucidSearch for biopharma-focused search, online KOL identification platform) give clients a practical edge.
Elevate Your Game in the Gene & Cell Therapy Space with Our Strategic Insights and Industry Expertise
We accelerate success in the competitive Gene and Cell therapy space by empowering clients to make the right decisions.
For our BioPharma clients, we provide insights and recommendations spanning R&D to commercialization, enabling accelerated growth and increased competitiveness. Our investor clients gain an edge with critical analyses to inform winning investment strategies and differentiation.
Our work is supported by primary KOL research, congress coverage, and competitive wargaming tailored to the unique dynamics of gene and cell therapy.
Identify and Overcome Challenges in This Ultra-Competitive Space With Our Strategic Intelligence Services
By providing actionable insights spanning the vaccine development lifecycle, we empower clients to rapidly develop and execute strategies that outpace the competition.
Our BioPharma clients gain an edge with strategic intelligence enabling swift asset advancement/ commercialization and differentiation. Investor clients stay ahead with our timely, critical analyses informing winning investment decisions and differentiation.
Our work is supported by primary KOL research, congress coverage, and competitive wargaming tailored to the fast-moving vaccines’ landscape.
Accelerate Your Winning Investment Strategies by De-Risking the Hunt for the Next Big Thing
We accelerate winning investment strategies by equipping clients with up-to-date, evidence-based insights and viable analyses.
Combining our in-house expertise and extensive network, we empower investors to execute differentiated propositions. For entrepreneurial ventures, we provide the vital link to kick-start or accelerate growth by connecting them with potential capital sources through our vast contact network.
We accelerate success and profitability for Pharma, Biotech, Healthcare, and Technology clients. Leveraging expertise and intelligence, we empower winning strategies through strategic insights, transformative digital solutions and tailored consulting across established and emerging opportunities.
Our team combines deep scientific training with hands-on biopharma, healthtech, and consulting experience. We don’t just analyze markets, we’ve worked in them.
We operate globally through our in-house experts and a dedicated network of partners, ensuring coverage across regions, time zones, and therapy areas.
Our clients include leading organizations in Pharma, Biotech, Digital Health, AI, Consumer Healthcare, and Health/Wellness.
We also partner with Hedge Funds, Private Equity, Venture Capital, angel investors, and startups by providing decision-grade intelligence to capitalize on opportunities.
Whether you need primary intelligence, congress coverage, a competitive wargame, or strategic advisory, let’s talk.